SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-009005
Filing Date
2024-03-05
Accepted
2024-03-05 17:09:47
Documents
30
Period of Report
2024-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20240305.htm   iXBRL 8-K 32281
2 EX-99.1 aqst-q423xex991earningsrel.htm EX-99.1 219596
3 EX-99.2 q423suppearningsmatl.htm EX-99.2 13773
7 aqstlogo.jpg GRAPHIC 14528
8 q423suppearningsmatl001.jpg GRAPHIC 91493
9 q423suppearningsmatl002.jpg GRAPHIC 268888
10 q423suppearningsmatl003.jpg GRAPHIC 89298
11 q423suppearningsmatl004.jpg GRAPHIC 76671
12 q423suppearningsmatl005.jpg GRAPHIC 44718
13 q423suppearningsmatl006.jpg GRAPHIC 59634
14 q423suppearningsmatl007.jpg GRAPHIC 65531
15 q423suppearningsmatl008.jpg GRAPHIC 41364
16 q423suppearningsmatl009.jpg GRAPHIC 96896
17 q423suppearningsmatl010.jpg GRAPHIC 99673
18 q423suppearningsmatl011.jpg GRAPHIC 82714
19 q423suppearningsmatl012.jpg GRAPHIC 58876
20 q423suppearningsmatl013.jpg GRAPHIC 37569
  Complete submission text file 0001628280-24-009005.txt   1965452

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20240305.xsd EX-101.SCH 1895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20240305_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20240305_pre.xml EX-101.PRE 12504
31 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20240305_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 24722156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)